Engaging pharmacies in tuberculosis control: operational lessons from 19 case detection interventions in high-burden countries
BMJ Glob Health
.
2022 Apr;7(4):e008661.
doi: 10.1136/bmjgh-2022-008661.
Authors
Jacob Bigio
1
2
,
Nathaly Aquilera Vasquez
3
2
,
Lavanya Huria
3
4
,
Tripti Pande
3
2
,
Jacob Creswell
5
,
Ramya Ananthakrishnan
6
,
John S Bimba
7
,
Luis E Cuevas
8
,
Luan Vo
9
,
Mirjam I Bakker
10
,
Md Toufiq Rahman
5
,
Madhukar Pai
3
11
Affiliations
1
McGill International TB Centre, Montreal, Quebec, Canada jacob.bigio@protonmail.com.
2
Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
3
McGill International TB Centre, Montreal, Quebec, Canada.
4
Department of Epidemiology and Biostatistics, McGill University Montreal, Montreal, Quebec, Canada.
5
Stop TB Partnership, Geneva, Switzerland.
6
Resource Group for Education and Advocacy for Community Health (REACH), Chennai, India.
7
Department of Community Medicine, Bingham University, Karu, Nigeria.
8
Clinical Sciences and Research Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, UK.
9
Friends for International TB Relief, Ha Noi, Viet Nam.
10
KIT Royal Tropical Institute, Amsterdam, Netherlands.
11
Epidemiology and Biostats, McGill University, Montreal, Quebec, Canada.
PMID:
35440442
PMCID:
PMC9020292
DOI:
10.1136/bmjgh-2022-008661
No abstract available
Keywords:
Public Health; Tuberculosis.
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Antitubercular Agents / therapeutic use
Humans
Pharmacies*
Tuberculosis* / diagnosis
Substances
Antitubercular Agents